[Dispensing Remuneration Notice Correction] Home Visit Comprehensive Support 2-B (100 points) Partially Applicable in Facilities for Individuals Requiring Level 3 or Higher Care, etc. – dgs-on

News Highlights

According to an article from dgs-on-line.com dated May 29, 2026, the dispensing remuneration notice has been revised to allow partial calculation of 100 points for “Home Visit Comprehensive Support 2-B” for facility residents, provided certain conditions are met, such as requiring Level 3 or higher care. This can be interpreted as an expansion of the scope of home medical care and an effort to improve the quality of medical services in facilities.

M&A Medical Editorial Department’s Perspective

This revision to the dispensing remuneration notice is a significant step in extending the scope of home medical care to include facility residents. The specific condition of “Level 3 or higher care” may encourage the development of a medical provision system for patients requiring more intensive care, for whom home care has been difficult until now. This creates opportunities for dispensing pharmacies to go beyond simply “delivering medication” and deepen their collaboration with facilities, serving as part of a multidisciplinary team to provide more comprehensive services. From an M&A perspective, this could impact the valuation of pharmacies co-located with facilities or those with strengths in providing home medical services to facilities. Furthermore, from the viewpoint of deepening the community-based integrated care system, enhanced collaboration of medical, nursing care, and pharmaceutical services within facilities will be required, increasing the value of businesses that undertake this role.

Points Raised by This News

• The scope of home medical care is expanding to facility residents, broadening the service provision range for pharmacies.
• The condition of “Level 3 or higher care” promotes the establishment of a medical provision system for severely disabled individuals.
• Enhanced facility collaboration by dispensing pharmacies serves as a catalyst for expanding their role within multidisciplinary teams.
• This may influence the evaluation of pharmacies with strengths in facility-based services in the M&A market.

Practical Questions Arising from This News

• Which specific types of facilities will be eligible for calculation under this remuneration revision?
• What preparations are necessary for pharmacies to strengthen collaboration with facilities?
• What is the specific workflow for pharmacists to meet the calculation requirements for Home Visit Comprehensive Support 2-B?

If You Feel “Should I Consult?”

Please consult with an expert to determine if your pharmacy can seize the opportunity for providing home medical services to facilities, expanded by this remuneration revision, and leverage it for business growth and increased revenue. Particularly, if you have a track record of collaborating with facilities and expertise in handling severely disabled individuals, it could lead to increased corporate value in M&A. It is important to promptly assess the current status and future potential of your business and consider the optimal strategy.

M&A Medical (CentralMedience Inc.) is an M&A support institution certified by the Small and Medium Enterprise Agency, providing support for the business succession of medical corporations, hospitals, and clinics on a full success fee basis. Consultations are accepted with strict confidentiality. Free consultations are available here.